Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM0TM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,794
Award facts
- Contract value 100% obligated
- $14,794.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,794.18 on December 17, 2025, for the supply of Beyfortus 50 mg/0.5 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be completed by December 18, 2025, with the product to be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract under a larger federal contract vehicle supporting the Defense Logistics Agency's medical supply procurement operations.
This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The company, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Beyfortus is a respiratory syncytial virus immunization product, reflecting the contractor's role in supplying critical preventive medications and vaccines for military personnel and related beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FM0TM?
SPE2DR26FM0TM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FM0TM worth?
The government has obligated $14,794 on SPE2DR26FM0TM.
Is contract SPE2DR26FM0TM an order under another contract?
Yes. SPE2DR26FM0TM is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM0TM competed?
The extent of competition for SPE2DR26FM0TM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award